Conventional dendritic cells type I with an enhanced type-I-IFN signaling underpin anti-tumor immune responses in brain metastases
Fiona James(Leeds Teaching Hospitals NHS Trust), Mihaela Lorger(University of Leeds), Elton J. R. Vasconcelos(Western University of Health Sciences), William J. Brackenbury(Yorkshire Cancer Research), David R. Westhead(University of Leeds), Tsuneyasu Kaisho(Wakayama Medical University), Nicola Ingram(University of Leeds), Alena Revalová(University of York), Andrew S. MacDonald(Centre for Inflammation Research), Zarnaz Hadi(University of Leeds), Dario Vinicio Guglietta(University of York), Christopher Fife(University of Leeds), Jennifer Williams(University of Leeds), Grace Mallett(Centre for Inflammation Research), Ashley Sunderland(University of Leeds), Merin Lawrence(University of Leeds)
Cited by 0
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
Membrane potential and cancer progression
|Frontiers in Physiology|2013|620
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
|American Journal Of Pathology|2010|353
A Novel LPS-Inducible C-Type Lectin Is a Transcriptional Target of NF-IL6 in Macrophages
|The Journal of Immunology|1999|285